Purchase Order N3239819P0001
Award Date 8/6/19
Potential Completion Date 9/20/19
Potential Value $125K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
JBSA FT SAM HOUSTON, TX 78234, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The contract is for the delivery of a flow cytometer with post-warranty service and maintenance options, for a total ceiling value of $53,640.00. The contract was awarded on a firm fixed-price basis, with no set-aside designation. Acea Biosciences has previously received numerous prime federal contract awards from various agencies, including the...
- This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The contract is a firm fixed-price purchase order with a potential value of $134,995.95. There was no set-aside designation for this award. Acea Biosciences is a life sciences company that provides specialized equipment, software, services, and expertise related to flow...
- This federal contract award to Acea Biosciences, Inc. is for a Real-Time Label-Free Cell Analysis System. The $83,000.00 firm-fixed-price purchase order was issued by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. Acea Biosciences, a for-profit organization, has received over 20 prime federal contracts from agencies including the Department of Agriculture, Department of Health and Human Services, Department of Veterans Affairs,...
- This is a $55,356.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a small business vendor, to provide a Real Time Cell Analyzer (RTCA) system and related post-warranty preventive maintenance services. The award was set aside for small businesses. Acea Biosciences is a subsidiary of Agilent Technologies, Inc., a leading provider of analytical instruments, software, and services for laboratory use. This contract supports the FDA's...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration to Acea Biosciences, Inc., a small business, for a preventive maintenance agreement on the company's ACEA Biosciences/xCELLigence Real-Time Cell Analysis (RTCA) Dual Purpose (DP) unit. The ceiling value of the contract is $6,600.00 with a period of performance through September 12, 2024. Acea Biosciences, Inc. is a subsidiary of the parent company Agilent Technologies, Inc., a major provider of analytical...
- This federal contract award was made by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The $99,000.00 firm fixed-price purchase order does not have a set-aside designation. Acea Biosciences, a for-profit life sciences company, has received over 20 prior federal contract awards from agencies including the USDA, HHS, VA, and Navy to provide...
- This federal contract award was made by the National Institute on Drug Abuse, a civilian agency, to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $4,987.50 firm fixed-price purchase order is for service agreement coverage of a NovoCyte Quanteon flow cytometer system and an xCELLigence RTCA CardioECR instrument. The award does not have a set-aside designation, indicating it was competed on a full and open basis. Acea Biosciences has received numerous prior federal...
- This is a one-year service agreement contract awarded to Acea Biosciences, Inc. by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services. The $12,290.40 firm-fixed price contract is for the provision of a flow cytometer instrument and related services. There is no set-aside designation indicated. Acea Biosciences is a subsidiary of Agilent Technologies, Inc., a leading provider of analytical instruments,...
- Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc., was awarded a firm fixed-price purchase order valued at $32,014.56 by a Southeast Area civilian federal agency to upgrade a NovoCycle 2060R system to a 3000 model. The contract, awarded on August 26, 2020, with performance in Athens, Georgia, was issued without a set-aside designation following a competitive solicitation process that opened on August 12, 2020. No major subcontractors were identified for this award. Acea...
- This one-year firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development to Acea Biosciences, Inc., a for-profit life sciences company that is a subsidiary of Agilent Technologies. The $8,705.70 contract is for an extended service warranty on a NovoCyte One laser system, which was likely procured by the NIH to support specialized research and testing. Acea Biosciences has...